Drug-Induced Sleep Endoscopy Performed in the Endoscopy Suite: A Resource Utilization Analysis.

Abstract

To analyze the resource utilization of performing drug-induced sleep endoscopy (DISE) procedures in an endoscopy suite (ES) setting as compared with the operating room (OR). A retrospective review of DISE procedures performed by a single attending surgeon from 2016 to 2018. Tertiary hospital. All patients undergoing sleep endoscopy without concurrent surgical procedures were included. No exclusion criteria were incorporated. Analysis assessed for differences in procedure-related expenditures, patient characteristics, anesthesia and surgeon time, and access to care. A total of 87 sleep endoscopies were included: 65 (74.7%) performed in the ES and 22 (25.3%) in the OR. Patient groups were similar in age and apnea-hypopnea index severity (<i>P</i> > .05). Patient body mass index was significantly higher for the ES group (<i>P</i> = .03). Total facility time, postoperative recovery time, anesthesia care time, and time in the surgical room were significantly decreased in the ES setting (<i>P</i> < .01). Surgical time was similar between the groups (<i>P</i> > .05). For ES procedures, total cost was reduced by 74% (<i>P</i> < .01). DISE in the ES resulted in a mean $5080 less in health system charges versus the OR group (<i>P</i> < .01). There were no treatment-related complications in either setting. The resource utilization profile of performing DISE can be significantly improved by transferring these procedures from the OR to the ES setting.